Phosphorylation of PRAS40 on Thr246 by PKB/AKT facilitates efficient phosphorylation of Ser183 by mTORC1.

[1]  D. Ouwens,et al.  The nuclear appearance of ERK1/2 and p38 determines the sequential induction of ATF2-Thr71 and ATF2-Thr69 phosphorylation by serum in JNK-deficient cells , 2009, Molecular and Cellular Endocrinology.

[2]  D. Ouwens,et al.  PRAS40: Target or modulator of mTORC1 signalling and insulin action? , 2009, Archives of physiology and biochemistry.

[3]  C. MacKintosh,et al.  Differential 14-3-3 Affinity Capture Reveals New Downstream Targets of Phosphatidylinositol 3-Kinase Signaling* , 2009, Molecular & Cellular Proteomics.

[4]  A. Tee,et al.  Mammalian target of rapamycin complex 1: signalling inputs, substrates and feedback mechanisms. , 2009, Cellular signalling.

[5]  R. Memmott,et al.  Akt-dependent and -independent mechanisms of mTOR regulation in cancer. , 2009, Cellular signalling.

[6]  P. Polak,et al.  mTOR and the control of whole body metabolism. , 2009, Current opinion in cell biology.

[7]  Jonathan R. Brestoff,et al.  Rapamycin does not improve insulin sensitivity despite elevated mammalian target of rapamycin complex 1 activity in muscles of ob/ob mice. , 2008, American journal of physiology. Regulatory, integrative and comparative physiology.

[8]  T. Harris,et al.  Regulation of Proline-rich Akt Substrate of 40 kDa (PRAS40) Function by Mammalian Target of Rapamycin Complex 1 (mTORC1)-mediated Phosphorylation* , 2008, Journal of Biological Chemistry.

[9]  B. Manning,et al.  The TSC1-TSC2 complex: a molecular switchboard controlling cell growth. , 2008, The Biochemical journal.

[10]  David E James,et al.  IRS1-independent defects define major nodes of insulin resistance. , 2008, Cell metabolism.

[11]  C. Proud,et al.  PRAS40 Is a Target for Mammalian Target of Rapamycin Complex 1 and Is Required for Signaling Downstream of This Complex* , 2007, Journal of Biological Chemistry.

[12]  A. Nakashima,et al.  The Proline-rich Akt Substrate of 40 kDa (PRAS40) Is a Physiological Substrate of Mammalian Target of Rapamycin Complex 1* , 2007, Journal of Biological Chemistry.

[13]  R. Roth,et al.  PRAS40 Regulates mTORC1 Kinase Activity by Functioning as a Direct Inhibitor of Substrate Binding* , 2007, Journal of Biological Chemistry.

[14]  J. Zierath,et al.  Insulin signaling and glucose transport in insulin resistant human skeletal muscle , 2007, Cell Biochemistry and Biophysics.

[15]  S. Carr,et al.  PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. , 2007, Molecular cell.

[16]  Timothy J. Griffin,et al.  Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40 , 2007, Nature Cell Biology.

[17]  H. Pijl,et al.  Loss of 50% of excess weight using a very low energy diet improves insulin-stimulated glucose disposal and skeletal muscle insulin signalling in obese insulin-treated type 2 diabetic patients , 2007, Diabetologia.

[18]  J. Eckel,et al.  Insulin-Mediated Phosphorylation of the Proline-Rich Akt Substrate PRAS40 Is Impaired in Insulin Target Tissues of High-Fat Diet–Fed Rats , 2006, Diabetes.

[19]  C. Kahn,et al.  Critical nodes in signalling pathways: insights into insulin action , 2006, Nature Reviews Molecular Cell Biology.

[20]  D. Ouwens,et al.  Transcription Factor 2 Kinase in Insulin-Induced Thr69 and Thr71 Phosphorylation of Activating The Role of c-Jun N-Terminal Kinase, p38, and Extracellular Signal-Regulated , 2006 .

[21]  R. Heine,et al.  Cardiac dysfunction induced by high-fat diet is associated with altered myocardial insulin signalling in rats , 2005, Diabetologia.

[22]  Atsushi Saito,et al.  Neuroprotective Role of a Proline-Rich Akt Substrate in Apoptotic Neuronal Cell Death after Stroke: Relationships with Nerve Growth Factor , 2004, The Journal of Neuroscience.

[23]  F. Carlotti,et al.  Lentiviral vectors efficiently transduce quiescent mature 3T3-L1 adipocytes. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[24]  M. Birnbaum,et al.  Identification of a Proline-rich Akt Substrate as a 14-3-3 Binding Partner* , 2003, The Journal of Biological Chemistry.

[25]  C. MacKintosh,et al.  Regulation of the 14-3-3-binding protein p39 by growth factors and nutrients in rat PC12 pheochromocytoma cells. , 2002, The Biochemical journal.

[26]  K. Inoki,et al.  TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling , 2002, Nature Cell Biology.

[27]  K. Kooistra,et al.  Growth factors can activate ATF2 via a two‐step mechanism: phosphorylation of Thr71 through the Ras–MEK–ERK pathway and of Thr69 through RalGDS–Src–p38 , 2002, The EMBO journal.

[28]  J. Blenis,et al.  Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. , 2002, Molecular cell.

[29]  Kevin N. Dalby,et al.  The Kinetic Mechanism of the Dual Phosphorylation of the ATF2 Transcription Factor by p38 Mitogen-activated Protein (MAP) Kinase α , 2001, The Journal of Biological Chemistry.

[30]  J. Heitman,et al.  Expression, enzyme activity, and subcellular localization of mammalian target of rapamycin in insulin-responsive cells. , 1997, Biochemical and biophysical research communications.

[31]  D. Ouwens,et al.  Activation of the Ras/mitogen-activated protein kinase signaling pathway alone is not sufficient to induce glucose uptake in 3T3-L1 adipocytes , 1994, Molecular and cellular biology.

[32]  R. Medema,et al.  Insulin stimulation of gene expression mediated by p21ras activation. , 1991, The EMBO journal.